Want to see GB:TATE full AI Analyst Report?
Earnings Data
Report Date
Nov 05, 2026Before Open (Confirmed)
Period Ending
2027 (Q2)Consensus EPS Forecast
0.21Last Year’s EPS
0.21Same Quarter Last Year
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The call presents a balanced picture: strong execution on integration, cost synergies and productivity, tangible pipeline growth and healthy liquidity contrast with disappointing like‑for‑like top‑line and EBITDA declines, a delayed bio‑gums benefit (~$20m phasing), one‑off integration charges and cash conversion below target. Management outlines clear actions to drive volume‑led growth and expects modest revenue growth in FY'27 (volume weighted to H2) with broadly flat EBITDA (excluding the bio‑gums timing impact), but near‑term performance remains exposed to tariffs, regional softness and cost pressures.Company Guidance
Integration of CP Kelco Completed
Integration of CP Kelco successfully completed without customer disruption; combination starting to gain traction with customers and enabling new cross-platform solutions.
Statutory Revenue and EBITDA Growth (Including CP Kelco)
On a statutory basis (including CP Kelco), revenue was 16% higher and adjusted EBITDA was 13% higher versus prior year.
Delivered Cost Synergies Ahead of Plan
Target of at least $50m annualized run-rate cost synergies by end of FY'27 achieved one year early; $24m delivered in the year and the annualized run rate now meets the $50m target.
Strong Productivity Delivery
Productivity savings of $53m delivered in the year (operational efficiencies $33m; procurement & supply chain $20m); total productivity savings of $144m over the last 3 years and 5-year target increased from $150m to $200m by end FY'28.
Growing New Business Pipeline and Innovation Metrics
New business pipeline value increased by 15%; revenue from new products up 9% (like-for-like); solutions represented 35% of new business wins; launched 8 chassis (18 live) and trained over 300 colleagues.
Asia Pacific Outperformance
Asia Pacific revenue broadly in line with prior year and EBITDA rose 9%, with North Asia growth and resilience despite tariff pressures in China.
Healthy Balance Sheet and Liquidity
Net debt reduced to GBP 939m (down GBP 22m); leverage at 2.3x (within 1–2.5x target); weighted average cost of debt ~4% and maturity 4.7 years; ~GBP 1bn of available liquidity including an $800m RCF extended to 2031.
Cross-selling and Revenue Synergy Progress
Revenue synergy target ~10% of CP Kelco revenue (~$70m by 2029); around 10% of that target delivered to date and cross-selling pipeline more than doubled in H2 to over $100m.
GB:TATE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GB:TATE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 21, 2026 | 509.89 p | 496.21 p | -2.68% |
Nov 06, 2025 | 362.91 p | 365.60 p | +0.74% |
May 22, 2025 | 564.69 p | 536.13 p | -5.06% |
Nov 07, 2024 | 718.50 p | 732.42 p | +1.94% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Tate & Lyle (GB:TATE) report earnings?
Tate & Lyle (GB:TATE) is schdueled to report earning on Nov 05, 2026, Before Open (Confirmed).
What is Tate & Lyle (GB:TATE) earnings time?
Tate & Lyle (GB:TATE) earnings time is at Nov 05, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Tate & Lyle stock?
The P/E ratio of Tate & Lyle is N/A.
What is GB:TATE EPS forecast?
GB:TATE EPS forecast for the fiscal quarter 2027 (Q2) is 0.21.